Dolby Laboratories, Inc. Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Dolby Laboratories, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Dolby Laboratories, Inc. for February 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 27 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | M | 30.49 | 10,000 | 304,900 | 12,919 | |
Feb 27 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 65.00 | 10,000 | 650,000 | 47,566 | 57.6 K to 47.6 K (-17.37 %) |
Feb 27 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Buy | M | 30.49 | 10,000 | 304,900 | 57,566 | 47.6 K to 57.6 K (+21.02 %) |
Feb 22 2018 | DLB | Dolby Laboratories ... | Forshay Steven E | SVP, Advanced Techn ... | Payment of Exercise | F | 63.37 | 408 | 25,855 | 65,410 | 65.8 K to 65.4 K (-0.62 %) |
Feb 13 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | M | 28.24 | 18,548 | 523,796 | 125,276 | |
Feb 13 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | M | 28.24 | 50,000 | 1,412,000 | 143,824 | |
Feb 13 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 61.40 | 18,548 | 1,138,856 | 62,895 | 81.4 K to 62.9 K (-22.77 %) |
Feb 13 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Buy | M | 28.24 | 18,548 | 523,796 | 81,443 | 62.9 K to 81.4 K (+29.49 %) |
Feb 13 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 60.65 | 2,200 | 133,427 | 62,895 | 65.1 K to 62.9 K (-3.38 %) |
Feb 13 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 59.92 | 7,896 | 473,160 | 65,095 | 73 K to 65.1 K (-10.82 %) |
Feb 13 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 58.75 | 39,904 | 2,344,308 | 72,991 | 112.9 K to 73 K (-35.35 %) |
Feb 13 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Buy | M | 28.24 | 50,000 | 1,412,000 | 112,895 | 62.9 K to 112.9 K (+79.50 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | M | 28.24 | 50,000 | 1,412,000 | 193,824 | |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | M | 28.24 | 16,781 | 473,895 | 243,824 | |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | M | 28.66 | 12,655 | 362,692 | 0 | |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 62.69 | 2,901 | 181,858 | 62,895 | 65.8 K to 62.9 K (-4.41 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 61.73 | 25,929 | 1,600,610 | 65,796 | 91.7 K to 65.8 K (-28.27 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 60.87 | 15,030 | 914,875 | 91,725 | 106.8 K to 91.7 K (-14.08 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 60.05 | 6,140 | 368,725 | 106,755 | 112.9 K to 106.8 K (-5.44 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Buy | M | 28.24 | 50,000 | 1,412,000 | 112,895 | 62.9 K to 112.9 K (+79.50 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 63.20 | 16,781 | 1,060,484 | 62,895 | 79.7 K to 62.9 K (-21.06 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Buy | M | 28.24 | 16,781 | 473,895 | 79,676 | 62.9 K to 79.7 K (+26.68 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 63.76 | 2,400 | 153,033 | 62,895 | 65.3 K to 62.9 K (-3.68 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 63.48 | 10,255 | 650,936 | 65,295 | 75.6 K to 65.3 K (-13.57 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Buy | M | 28.66 | 12,655 | 362,692 | 75,550 | 62.9 K to 75.6 K (+20.12 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 63.73 | 2,501 | 159,387 | 62,895 | 65.4 K to 62.9 K (-3.82 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 63.28 | 18,063 | 1,143,021 | 65,396 | 83.5 K to 65.4 K (-21.64 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | M | 30.49 | 31,554 | 962,081 | 22,919 | |
Feb 09 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | M | 30.49 | 7,227 | 220,351 | 54,473 | |
Feb 09 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | M | 28.24 | 41,219 | 1,164,025 | 0 | |
Feb 09 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 63.05 | 500 | 31,525 | 47,566 | 48.1 K to 47.6 K (-1.04 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 62.17 | 3,254 | 202,306 | 48,066 | 51.3 K to 48.1 K (-6.34 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 61.56 | 18,000 | 1,107,994 | 51,320 | 69.3 K to 51.3 K (-25.97 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 60.44 | 9,800 | 592,274 | 69,320 | 79.1 K to 69.3 K (-12.39 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Buy | M | 30.49 | 31,554 | 962,081 | 79,120 | 47.6 K to 79.1 K (+66.34 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 63.20 | 7,227 | 456,746 | 47,566 | 54.8 K to 47.6 K (-13.19 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Buy | M | 30.49 | 7,227 | 220,351 | 54,793 | 47.6 K to 54.8 K (+15.19 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 63.67 | 7,401 | 471,239 | 47,566 | 55 K to 47.6 K (-13.46 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 63.24 | 33,818 | 2,138,583 | 54,967 | 88.8 K to 55 K (-38.09 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Buy | M | 28.24 | 41,219 | 1,164,025 | 88,785 | 47.6 K to 88.8 K (+86.66 %) |
Feb 09 2018 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 63.10 | 1,554 | 98,057 | 47,566 | 49.1 K to 47.6 K (-3.16 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | Chau Micheline | Director | Grant | A | 0.00 | 3,920 | 0 | 50,519 | 46.6 K to 50.5 K (+8.41 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | GOTCHER PETER C | Director | Sell | S | 62.79 | 100 | 6,279 | 45,903 | 46 K to 45.9 K (-0.22 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | GOTCHER PETER C | Director | Sell | S | 62.21 | 4,700 | 292,405 | 46,103 | 50.8 K to 46.1 K (-9.25 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | GOTCHER PETER C | Director | Sell | S | 60.89 | 433 | 26,365 | 50,703 | 51.1 K to 50.7 K (-0.85 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | GOTCHER PETER C | Director | Grant | A | 0.00 | 3,920 | 0 | 51,136 | 47.2 K to 51.1 K (+8.30 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | TEVANIAN AVADIS | Director | Sell | S | 62.23 | 1,817 | 113,067 | 44,790 | 46.6 K to 44.8 K (-3.90 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | TEVANIAN AVADIS | Director | Sell | S | 61.60 | 800 | 49,277 | 46,607 | 47.4 K to 46.6 K (-1.69 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | TEVANIAN AVADIS | Director | Grant | A | 0.00 | 3,920 | 0 | 3,920 | 0 to 3.9 K |
Feb 08 2018 | DLB | Dolby Laboratories ... | SIBONI ROGER S | Director | Grant | A | 0.00 | 3,920 | 0 | 24,487 | 20.6 K to 24.5 K (+19.06 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | Segars Simon | Director | Grant | A | 0.00 | 3,920 | 0 | 24,487 | 20.6 K to 24.5 K (+19.06 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | JASPER N WILLIAM JR | Director | Sell | S | 62.79 | 100 | 6,279 | 7,000 | 7.1 K to 7 K (-1.41 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | JASPER N WILLIAM JR | Director | Sell | S | 62.21 | 4,700 | 292,395 | 7,100 | 11.8 K to 7.1 K (-39.83 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | JASPER N WILLIAM JR | Director | Sell | S | 60.86 | 433 | 26,350 | 11,800 | 12.2 K to 11.8 K (-3.54 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | JASPER N WILLIAM JR | Director | Grant | A | 0.00 | 3,920 | 0 | 3,920 | 0 to 3.9 K |
Feb 08 2018 | DLB | Dolby Laboratories ... | DONATIELLO NICHOLAS JR | Director | Sell | S | 62.11 | 2,417 | 150,130 | 20,911 | 23.3 K to 20.9 K (-10.36 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | DONATIELLO NICHOLAS JR | Director | Sell | S | 60.63 | 200 | 12,126 | 23,328 | 23.5 K to 23.3 K (-0.85 %) |
Feb 08 2018 | DLB | Dolby Laboratories ... | DONATIELLO NICHOLAS JR | Director | Grant | A | 0.00 | 3,920 | 0 | 3,920 | 0 to 3.9 K |
Feb 08 2018 | DLB | Dolby Laboratories ... | Dolby David | Director | Grant | A | 0.00 | 3,920 | 0 | 65,070 | 61.2 K to 65.1 K (+6.41 %) |